GlassScriptPhysician profile
Brian M Celico
NPI 1790767309
$2,136.06
in general payments reported to CMS, 2019-2025
13 companies · $612 in 2025
The $612 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2023: $728 · 2024: $552 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799 · Entertainment: $92.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.14 |
| Entertainment | $92.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $351.49 | 2023-2024 | |
| Dompe US, INC. | $270.61 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $241.09 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $227.42 | 2023-2025 | Infuse |
| Glaukos Corporation | $167.75 | 2025 | |
| Alcon Vision LLC | $153.40 | 2024 | Total30 |
| Genentech USA, INC. | $122.16 | 2019 | |
| Genzyme Corporation | $121.95 | 2019 | |
| Biotissue Holdings INC. | $108.20 | 2024 | |
| Abbvie INC. | $102.15 | 2023 | Xen Glaucoma Treatment System |
| Coopervision INC. | $97.03 | 2024 | Misight Contact Lens |
| Optos, INC. | $92.81 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $80.00 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Celico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.